Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @ionispharma
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ionispharma
-
Prikvačeni tweetHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
-
Only 2 weeks left to apply for an intership at Ionis! Take a look at our job board for all open summer intern positions here: http://bit.ly/3072263 pic.twitter.com/EQrlZ2Ztnx
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ion Michael McCaleb, VP of Clinical Development, sums up what saying
#Yesin2020 is all about at Ionis.pic.twitter.com/L56FaUWEyuHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Here's what Ion Frank Rigo, VP of Functional Genomics, had to say about turning yes into
#hope in 2020? Are you saying#YESin2020?pic.twitter.com/Vy1q8Ol8ztHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Akcea and Ionis report positive topline phase 2 study results of AKCEA-ANGPTL3-LRx. Read more:https://bit.ly/37AOkv9
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Excited about our collaboration with
@OHSUKnight to develop undruggable#cancer targets.#Yesin2020#theionispipeline@OHSUNewshttps://twitter.com/OHSUKnight/status/1221897919332257794 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We're cracking the code on neurodegenerative diseases!
@BPMonia discussed our validated platform, expanding pipeline, and continued technology advancements during his#JPM20 presentation. Watch the#replay here: https://bit.ly/3aCPS9V#JPM2020pic.twitter.com/LtuasjgAcN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
See how Ion Fiona An, Executive Director of Clinical Development, plans to make yes happen this year!
#hope#Yesin2020pic.twitter.com/IRjpzbdLKOHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our leadership position in RNA-targeted therapeutics continues to grow as our technology advances. Learn more in the
#replay of@BPMonia's#JPM20 presentation: https://bit.ly/3aCPS9V#Yesin2020#JPM2020pic.twitter.com/JulIE8uNS5
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
New Year. New opportunities to say Yes, to patients, to science, to innovation. We asked our employees (Ions) what they're hoping to say yes to in 2020. Here's Ion Punit Seth, VP of Medicinal Chemistry.
#Yesin2020pic.twitter.com/p85rGKL7WVHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Interested in a career in biotech? Check out our summer internships in science, research and development, corporate communications, business operations and more! We’ll be accepting applications until Feb. 14. Apply now! https://www.ionispharma.com/careers/intern-program/ …pic.twitter.com/zPnnWsWmSQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Akcea and Ionis report positive topline Phase 2 results of AKCEA-APOCIII-L Rxhttps://prn.to/30GKmOU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Couldn’t make it to
#JPM20? Check out our REPLAY of CEO@BPMonia’s presentation from the conference.#JPM2020 https://bit.ly/2RcgsPs pic.twitter.com/JEE8FrpHGX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Don't forget! Watch CEO
@BPMonia's presentation live from the J.P. Morgan 38th Annual Healthcare Conference today at 7:30 AM PST. Join here: https://bit.ly/2tZ2iZ3#JPM20#JPM2020pic.twitter.com/B5wRIEan6V
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our latest clinical trial site for TTR has launched. Visit http://www.CARDIO-TTRansform.com to learn about our study for transthyretin mediated amyloid cardiomyopathy (ATTR CM) patients.
#powerofYes https://bit.ly/37NMiYi pic.twitter.com/XwazLokeCyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Please join us in welcoming our new Chief Corporate Development and Commercial Officer Onaiza Cadoret-Manier! Read more: https://bit.ly/37WueLT pic.twitter.com/ykTRBrsyaF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ionis appoints Onaiza Cadoret-Manier as chief corporate development and commercial officer https://prn.to/35xh5qZ pic.twitter.com/KwPOZNZQgv
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
At Ionis, patients are the reason we come to work every day. We are honored to join our colleagues around the world in reinforcing our commitment to improving the lives of the sick people who depend on us. Read more: https://bit.ly/304bNlA
@statnewsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our
#neuro franchise closed 2019 with a bang! With#antisense pipeline advances, prolific scientific publication & prestigious award recognition, we’ve solidified our position as a leading neuro program.#theionispipeline#RealityofYES Read more: https://bit.ly/36zvTX8$IONSpic.twitter.com/mjUcsyZxIu
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Ionis’ neurological franchise marks year of achievement https://prn.to/2N2K8w6 pic.twitter.com/hE1HLNHstc
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Please join us for a live presentation and webcast featuring our new CEO Brett Monia, Ph.D. at next week’s J.P. Morgan 38th Annual Healthcare Conference.
#JPM2020pic.twitter.com/g4nxSpTawH
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.